NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
13.04
-1.19 (-8.36%)
At close: Mar 6, 2026, 4:00 PM EST
13.00
-0.04 (-0.30%)
After-hours: Mar 6, 2026, 7:42 PM EST
NovoCure Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 655.35 | 605.22 | 509.34 | 537.84 | 535.03 | Upgrade
|
| Revenue Growth (YoY) | 8.28% | 18.82% | -5.30% | 0.53% | 8.23% | Upgrade
|
| Cost of Revenue | 165.17 | 136.18 | 127.54 | 114.26 | 114.24 | Upgrade
|
| Gross Profit | 490.18 | 469.05 | 381.8 | 423.58 | 420.79 | Upgrade
|
| Selling, General & Admin | 413.93 | 427.21 | 386.97 | 306.41 | 263.18 | Upgrade
|
| Research & Development | 224.54 | 209.37 | 220.99 | 206.09 | 201.3 | Upgrade
|
| Operating Expenses | 638.47 | 636.58 | 607.96 | 512.5 | 464.49 | Upgrade
|
| Operating Income | -148.29 | -167.54 | -226.16 | -88.91 | -43.69 | Upgrade
|
| Interest Expense | -17.04 | -11.49 | -3.32 | -3.33 | -3.44 | Upgrade
|
| Interest & Investment Income | 12.87 | 22.72 | 19.64 | 10.96 | 0.79 | Upgrade
|
| Currency Exchange Gain (Loss) | -4.32 | -0.72 | -0.8 | -3.52 | -4.03 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.86 | -0.6 | -0.79 | -1.26 | -1.37 | Upgrade
|
| EBT Excluding Unusual Items | -157.63 | -157.62 | -211.42 | -86.06 | -51.74 | Upgrade
|
| Merger & Restructuring Charges | -2.2 | -2 | -6.23 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 26.89 | 28.27 | 26.4 | 4.83 | 0.31 | Upgrade
|
| Asset Writedown | -3.31 | -0.95 | -0.48 | -0.61 | -0.64 | Upgrade
|
| Other Unusual Items | - | 1.14 | - | - | - | Upgrade
|
| Pretax Income | -136.25 | -131.16 | -191.74 | -81.85 | -52.08 | Upgrade
|
| Income Tax Expense | -0.02 | 37.47 | 15.3 | 10.69 | 6.28 | Upgrade
|
| Net Income | -136.23 | -168.63 | -207.04 | -92.53 | -58.35 | Upgrade
|
| Net Income to Common | -136.23 | -168.63 | -207.04 | -92.53 | -58.35 | Upgrade
|
| Shares Outstanding (Basic) | 111 | 108 | 106 | 105 | 103 | Upgrade
|
| Shares Outstanding (Diluted) | 111 | 108 | 106 | 105 | 103 | Upgrade
|
| Shares Change (YoY) | 3.37% | 1.36% | 1.65% | 1.19% | -5.00% | Upgrade
|
| EPS (Basic) | -1.22 | -1.56 | -1.95 | -0.88 | -0.56 | Upgrade
|
| EPS (Diluted) | -1.22 | -1.56 | -1.95 | -0.88 | -0.56 | Upgrade
|
| Free Cash Flow | -75.68 | -69.22 | -100.43 | 9.43 | 58.59 | Upgrade
|
| Free Cash Flow Per Share | -0.68 | -0.64 | -0.94 | 0.09 | 0.57 | Upgrade
|
| Gross Margin | 74.80% | 77.50% | 74.96% | 78.76% | 78.65% | Upgrade
|
| Operating Margin | -22.63% | -27.68% | -44.40% | -16.53% | -8.17% | Upgrade
|
| Profit Margin | -20.79% | -27.86% | -40.65% | -17.21% | -10.91% | Upgrade
|
| Free Cash Flow Margin | -11.55% | -11.44% | -19.72% | 1.75% | 10.95% | Upgrade
|
| EBITDA | -135.16 | -157.67 | -216.46 | -79.34 | -34.53 | Upgrade
|
| EBITDA Margin | -20.62% | -26.05% | -42.50% | -14.75% | -6.45% | Upgrade
|
| D&A For EBITDA | 13.13 | 9.87 | 9.7 | 9.57 | 9.17 | Upgrade
|
| EBIT | -148.29 | -167.54 | -226.16 | -88.91 | -43.69 | Upgrade
|
| EBIT Margin | -22.63% | -27.68% | -44.40% | -16.53% | -8.17% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.